TECX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Tectonic Therapeutic, Inc. · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 28.03 USD
-7.7% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is -1.0% below the Trend Line and sits at 54.3% of its 52-week range. The latest completed week returned -7.7%, after a -26.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 53/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: earnings are due in 4d.

Setup score 44 out of 100
Latest Close 28.03 USD 31 Jul 2026
1W Return -7.7% latest completed week
4W Return -26.1% short-term follow-through
12W Return -3.3% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 1.0x vs 13-week average
What is working
  • The trend backdrop is active with a 25-week active streak.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -7.7% Latest completed week; four-week move -26.1%. Indicator stack 71/52 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 53/100 conviction; expected move 19.1%. News sentiment 55/100 47 relevant articles in the latest sentiment read. Event risk 4d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is -1.0% below the Trend Line and sits at 54.3% of its 52-week range. The latest completed week returned -7.7%, after a -26.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8712-week average 0.84

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.87Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -26.1% over four weeks, -3.3% over 12 weeks, and 35.2% over one year. The current trend has remained active for 25 consecutive weeks.

Performance by holding period

1W-7.7%
4W-26.1%
12W-3.3%
26W40.2%
52W35.2%
Active trend streak25 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.08Latest activity-pressure read.
Pressure change49.1%Four-week change in activity pressure.
Leadership5.43Latest relative-leadership reading.
RS change-86.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 61% Model confidence 58%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength34/100Blend of value, momentum, and quality. Underlying universe rank 67; rank 1 is best.
Value43/100Relative valuation strength. Underlying universe rank 58; rank 1 is best.
Quality41/100Profitability and accounting quality. Underlying universe rank 60; rank 1 is best.
Momentum43/100Medium-term price momentum. Underlying universe rank 58; rank 1 is best.
Growth43/100Revenue and earnings growth. Underlying universe rank 58; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-19.1%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-30.2%
Net share repurchases relative to market value.
Shareholder yield
-30.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
2.9x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

TECX shows volatility options pressure with a 53/100 conviction score, put-call volume ratio of 0.00, expected move of 19.1%, and Sharemaestro trend signal active.

Conviction53/100
Expected move19.1%
Put/call volume0.00
Pressure100
Speculation8
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 47 relevant articles.

15 positive · 27 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings4dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move19.1%Nearest-chain priced movement where available.
52-week drawdown-29.1%Distance below the 52-week high.
13-week volatility7.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+53.0%Week of 6 Mar.
Worst week-10.3%Week of 20 Mar.
Latest week-7.7%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains3
Flat weeks0
Modest losses6
Sharp losses9
Recent vol7.6%13-week weekly-return volatility.
Base vol11.3%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew8.4% / -6.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape53/100

Trend, activity pressure, participation, and risk combine to a 53/100 tape read.

 Indicator analysis75/100

Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 12/12.

Activity pressure 0.87; No reversal markers Factors39/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 93; Small Cap Core rank 59 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options36/100

TECX shows volatility options pressure with a 53/100 conviction score, put-call volume ratio of 0.00, expected move of 19.1%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 19.1% Sentiment55/100

Weighted news tone is neutral across 47 relevant articles.

Tectonic Therapeutic Inc (TECX) Earnings Forecast: Future EPS & Revenue Growth Estimates Insiders50/100

No recent insider transaction evidence is stored.

 Earnings4d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202628.03 USD-7.7%28.32 USD23.55 USD-0.085.43911.0KOn
24 Jul 202630.37 USD-6.8%28.08 USD23.49 USD0.3515.04623.9KOn
17 Jul 202632.60 USD-5.1%27.76 USD23.41 USD0.4521.811.1MOn
10 Jul 202634.37 USD-9.4%27.33 USD23.32 USD0.1923.551.2MOn
3 Jul 202637.93 USD18.6%26.84 USD23.21 USD-0.1739.271.2MOn
26 Jun 202631.99 USD6.6%26.24 USD23.04 USD-0.5919.35676.1KOn
19 Jun 202630.02 USD-0.9%25.89 USD22.91 USD-0.567.45489.0KOn
12 Jun 202630.28 USD4.4%25.53 USD22.78 USD-0.4311.44705.4KOn
5 Jun 202629.00 USD-6.9%25.14 USD22.68 USD-0.339.21628.8KOn
29 May 202631.16 USD7.0%24.81 USD22.59 USD-0.1311.931.0MOn
22 May 202629.12 USD4.4%24.38 USD22.47 USD-0.077.65987.2KOn
15 May 202627.89 USD-3.8%23.98 USD22.38 USD0.144.241.5MOn
8 May 202629.00 USD-0.2%23.63 USD22.26 USD0.397.981.2MOn
1 May 202629.06 USD1.8%23.20 USD22.12 USD0.5914.17812.5KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.